Benzinga | Dec 21, 2021 08:02AM EST

NanoVibronix Announces Agreement With Medina Healthcare Limited For Distribution Of UroShield And PainShield In European Market Expansion

NanoVibronix Inc., (NASDAQ:NAOV), a medical device company that produces the UroShield(r) and PainShield(r) Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has commenced sales in Europe with the signing of a distribution agreement with Medina Healthcare Ltd ("Medina") in Malta.

Brian Murphy, Chief Executive Officer of NanoVibronix Inc., commented, "NanoVibronix have has already obtained regulatory approval to sell our range of devices into all European countries. We are eager to leverage Medina's strong distribution capabilities in Malta and establish a foothold that will help us achieve broader distribution to other parts of Europe. This agreement is consistent with our strategy to partner with leading organizations that have significant sales resources and can rapidly penetrate global markets. Medina placed its initial order validating their confidence in our technology and the market potential for our devices. UroShield enables clinicians to potentially prevent the incidence of infections in the most vulnerable, and PainShield will empower patients to manage their chronic pain at a critical time for our healthcare system."

Medina Healthcare Ltd. provides a comprehensive range of medical solutions that address the changing needs of European healthcare.

John Soler, CEO of Medina Healthcare Ltd commented, "Following discussions with clinicians, we anticipate strong uptake of UroShield and PainShield devices as medical professionals seek minimally invasive, consumable devices that enable the delivery of the best therapies for their patients. The partnership with NanoVibronix allows us to provide solutions that both prevent the incidence of infections in the most vulnerable patients and help many people gain relief from chronic pain."

UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm on indwelling urinary catheters and increase antibiotic efficacy, ultimately reducing the incidence of catheter-associated urinary tract infections (CAUTI). UroShield is also intended to decrease pain and discomfort associated with urinary catheter use.

PainShield is an ultrasound device, consisting of a reusable driver unit and a disposable patch, which contains a proprietary therapeutic transducer. PainShield delivers a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area, while keeping the level of ultrasound energy at a safe and consistent level. Its range of applications includes acute and chronic pain resolution through its many mechanisms of action. The product has been acknowledged by several sports icons and has broad applications for sports injuries. PainShield can be used by patients at home or work or in a clinical setting and can be used even while the patient is sleeping. Patient benefits include ease of application and use, faster recovery time, high compliance, and increased safety and efficacy over existing devices that rely on higher-frequency ultrasound.